• Home
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Journal PharmaceuticalIntelligence.com
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder
  • Funding, Deals & Partnerships
  • LPBI Group News
  • CALENDAR
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2022 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • SOP Web STAT
  • Blockchain Transactions Network Ecosystem
  • Contact Us
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • Synthetic Biology in Drug Discovery
  • Certificate One Year

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Funding, Deals & Partnerships: BIOLOGICS & MEDICAL DEVICES; BioMed e-Series; Medicine and Life Sciences Scientific Journal – http://PharmaceuticalIntelligence.com

Feeds:
Posts
Comments

e-Proceedings and Tweet Collections per Conference, 2013-2020, # Views = Downloads x $100: Real Time Coverage of 60 Events by ALA & SJW 

e-Proceedings and Tweet Collections per Conference, 2013-2020, # Views = Downloads x $100: Real Time Coverage of 60 Events by ALA & SJW

Curators: Aviva Lev-Ari, PhD, RN and Stephen J Williams, PhD

 

  • The data presented below is compiled from the following sources.

  • Views per documents published in realtime at the events fetched from the Site statistics on 2/2020.

Press Coverage is a Service that we offer to Biotech and Medicine, Scientific and Business Conference Organizers.

 

Click on these Links

 

  • Part One: The Process of Real Time Coverage using Social Media

  • Part Two: List of BioTech Conferences 2013 to Present

  • Part Three: Conference eProceedings DELIVERABLES & Social Media Analytics

 

 

  • 60 eProceedings & 36 Collections of Tweets, 2013 – 2019

REVENUE POTENTIAL FROM downloads of 96 items –

Valuation of the Archives based downloads = Views = 13,685)

@ $100 per download $1,368,500

YEAR            Tweet Collections (TC)       

# of Views

 $ Grand Total 

e-Proceedings & Tweet Collections  

$

 Grand Total Views
     Total               Aviva Lev-Ari & Stephen J Williams 1,090 109,000 1,368,500 13,685
Fraction – ALA 96% 84%
Fraction – SJW 4% 16%
YEAR            TC             # of Views $ Grand Total $ Grand Total Views
Total                       Aviva Lev-Ari 1,051 105,100 1,150,100 11,501
2020
2019 264 26,400
2018 213 21,300
2017 88 8,800
2016 246 24,600
2015 104 10,400
2014-2013 136 13,600
YEAR            TC             # of Views $ Grand Total $ Grand Total Views
Total                       Stephen J Willams 39 3,900 218,400 2,184
2020
2019
2018 22 2,200
2016-2017
2015 17 1,700
2014-2013

YEAR # Events Covered generating e-Proceedings (some events covered by iPhone Tweeting Pictures and Comments, only) Event counted as 1 even if it generated multiple article entires      e-Proceedings       # of Views $                

 

 

    Tweets Collections       (TC) generated         # Items
     Total               Aviva Lev-Ari & Stephen J Williams 60 12,595 1,259,500 36
Fraction – ALA 77% 83% 94%
Fraction – SJW 23% 17% 6%
YEAR # Events Covered generating e-Proceeding (some events covered by iPhone Tweeting Pictures and Comments, only) Event counted as 1 even if it generated multiple article entires      e-Proceedings       # of Views $    Tweets Collections       (TC) generated         # Items
Total                       Aviva Lev-Ari 46 10,450 1,045,000 34
2020 1 1
2019 11 955 95,500 8
2018 8 1,120 112,000 7
2017 5 469 46,900 3
2016 8 2,287 228,700 7
2015 5 2,383 238,300 5
2014-2013 8 3,236 323,600 3
YEAR # Events Covered generating e-Proceeding (some events covered by iPhone Tweeting Pictures and Comments, only) Event counted as 1 even if it generated multiple article entires      e-Proceedings       # of Views $    Tweets Collections       (TC) generated         # Items
Total                       Stephen J Willams 14 2,145 214,500 2
2020 1 61 6,100
2019 2 438 43,800
2018 2 352 35,200 1
2016-2017 3 105 10,500
2015 4 672 67,200 1
2014-2013 2 517 51,700

 

YEAR             Tweet Collections   # of Views $ Grand Total $ Grand Total Views

     Total               Aviva Lev-Ari & Stephen J Williams

1,090

109,000

1,368,500

13,685
Fraction – ALA 96% 84%
Fraction – SJW 4% 16%
YEAR           Tweet Collections   # of Views $ Grand Total $ Grand Total Views
Total                       Aviva Lev-Ari 1051 105100 1,150,100 11,501
2020
2019 264 26,400
2018 213 21,300
2017 88 8,800
2016 246 24,600
2015 104 10,400
2014-2013 136 13,600
YEAR           Tweet Collections   # of Views $ Grand Total $ Grand Total Views
Total                       Stephen J Willams 39 3,900 218,400 2,184
2020
2019
2018 22 2,200
2016-2017
2015 17 1,700
2014-2013

Share this:

  • Tweet
  • Print
  • Email
  • More

Like this:

Like Loading...

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 2,686 other subscribers

  • Recent Posts

    • FDA Approves First Drug to Improve Growth in Children with Most Common Form of Dwarfism November 22, 2021
    • Defective viral RNA sensing gene OAS1 linked to severe COVID-19 November 22, 2021
    • Moderna Vaccine Patent Application needs to include Names of Three NIH Scientists that Shared the Genome Sequence of SAR-Cov-2 with Moderna Early on November 11, 2021
    • Epidemiologic measurement on COVID-19 pandemic may have statistical biases which might affect next variant responses November 7, 2021
    • The Vibrant Philly Biotech Scene: Proteovant Therapeutics Using Artificial Intelligence and Machine Learning to Develop PROTACs October 26, 2021
    • The Map of human proteins drawn by artificial intelligence and PROTAC (proteolysis targeting chimeras) Technology for Drug Discovery October 21, 2021
    • Breakthrough Procedure in Aortic Valve Repair: VIDEO: How to Perform a Transcaval TAVR Procedure October 16, 2021
    • Comparative Study: Four SARS-CoV-2 vaccines induce quantitatively different antibody responses against SARS-CoV-2 variants October 16, 2021
    • A laboratory for the use of AI for drug development has been launched in collaboration with Pfizer, Teva, AstraZeneca, Mark and Amazon October 16, 2021
    • Greylock Partners Announces Unique $500 Million Venture to act as Seed Capital Funding for Earliest Stage Startups October 16, 2021

  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    • 1 2012pharmaceutical
    • 1 Amandeep Kaur
    • 1 Aashir Awan, Phd
    • 1 Abhisar Anand
    • 1 Adina Hazan
    • 1 Alan F. Kaul, PharmD., MS, MBA, FCCP
    • 1 alexcrystal6
    • 1 anamikasarkar
    • 1 apreconasia
    • 1 aviralvatsa
    • 1 David Orchard-Webb, PhD
    • 1 danutdaagmailcom
    • 1 Demet Sag, Ph.D., CRA, GCP
    • 1 Daniel Menzin
    • 1 Dror Nir
    • 1 dsmolyar
    • 1 Ethan Coomber
    • 1 evelinacohn
    • 1 Gail S Thornton
    • 1 Irina Robu
    • 1 jayzmit48
    • 1 jdpmd
    • 1 jshertok
    • 1 kellyperlman
    • 1 Ed Kislauskis
    • 1 komal23ingle
    • 1 larryhbern
    • 1 Madison Davis
    • 1 marzankhan
    • 1 megbaker58
    • 1 ofermar2020
    • 1 Dr. Pati
    • 1 pkandala
    • 1 Rosalind Codrington, PhD
    • 1 ritusaxena
    • 1 Rick Mandahl
    • 1 satwik Sunnam
    • 1 sjwilliamspa
    • 1 Srinivas Sriram
    • 1 stuartlpbi
    • 1 Dr. Sudipta Saha
    • 1 tildabarliya
    • 1 vaishnavee24
    • 1 zraviv06
    • 1 zs22

Powered by WordPress.com.

WPThemes.


loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
%d bloggers like this: